comparemela.com

Latest Breaking News On - Tianqing - Page 1 : comparemela.com

Small Lymphocytic Lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical And Discovery Stage Product, And Companies 2024 (Updated)

Small Lymphocytic Lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical And Discovery Stage Product, And Companies 2024 (Updated)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Tianqing
Zhejiang
China
Chinese
Jiangsu-mingsight
Iovance-biotherapeutics
Ascentage-pharma
Route-of-administration
Company-name
Products-development
Mingsight-pharmaceuticals
Chia-tai-tianqing-pharmaceutical-group

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short Interest

Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tianqing
Zhejiang
China
Nanyue
Yunnan
Tianyun
Henan
Chinese
Sino-biopharmaceutical-limited
Sino-biopharmaceutical
Get-free-report

Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Down 12.7%

Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Down 12.7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nanyue
Yunnan
China
Tianyun
Henan
Tianqing
Zhejiang
Chinese
Sino-biopharmaceutical-limited
Sino-biopharmaceutical
Sino-biopharmaceutical-company-profile

Inventiva reports its 2023 full-year results

Inventiva reports its 2023 full-year results
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

China
France
Daix
Bourgogne
Israel
Cambridge
Cambridgeshire
United-kingdom
Milan
Lombardia
Italy
United-states

Akeso Marks Profit Milestone With Swift Rights Issue - Summit Therapeutics (NASDAQ:SMMT)

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen

Hong-kong
United-states
Tianqing
Zhejiang
China
Canada
Japan
Chinese
Molly-wen
Akeso-inc
Chia-tai-tianqing-pharmaceutical-group
Citibank

vimarsana © 2020. All Rights Reserved.